Who Owns Pacific Biosciences of California Stock?
NASDAQ: PACBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 55.44%
- Held by insiders
- 8.91%
- Institutional holders
- 299
- Institutions 55.4%
- Insiders 8.9%
- Public and other 35.7%
Who owns Pacific Biosciences of California stock?
Institutional investors own about 55.4% of Pacific Biosciences of California's shares, spread across 299 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 8.91% of PACB.
The largest institutional holders are Blackrock Inc. (10.40%), ARK Investment Management, LLC (9.58%) and Softbank Group Corporation (6.58%). Together, the top 10 institutions control 42.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their PACB positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PACB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 32.34M | 10.40% | +28.0% |
| ARK Investment Management, LLC | 29.78M | 9.58% | -17.9% |
| Softbank Group Corporation | 20.45M | 6.58% | 0.0% |
| Vanguard Capital Management LLC | 13.40M | 4.31% | +4.9% |
| Geode Capital Management, LLC | 7.61M | 2.45% | +9.1% |
| Sumitomo Mitsui Trust Group, Inc. | 6.01M | 1.93% | -14.6% |
| Amova Asset Management Americas Inc | 6.01M | 1.93% | -14.6% |
| State Street Corporation | 5.96M | 1.92% | -2.6% |
| Point72 Asset Management, L.P. | 4.79M | 1.54% | +1575.6% |
| Two Sigma Investments, LP | 4.24M | 1.36% | +20.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PACB
| Fund | Shares | % Held |
|---|---|---|
| ARK ETF Trust-ARK Innovation ETF | 12.26M | 3.94% |
| ARK ETF Trust-ARK Genomic Revolution ETF | 11.24M | 3.61% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 9.54M | 3.07% |
| iShares Trust-iShares Russell 2000 ETF | 7.24M | 2.33% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 3.58M | 1.15% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 3.06M | 0.98% |
| iShares Trust-iShares Russell 2000 Growth ETF | 2.49M | 0.80% |
| iShares Trust-iShares Biotechnology ETF | 2.17M | 0.70% |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | 2.09M | 0.67% |
| ARK Venture Fund | 1.73M | 0.56% |
Frequently asked questions
Who is the largest shareholder of Pacific Biosciences of California?
Blackrock Inc. is the largest institutional shareholder of PACB, owning 10.40% of shares outstanding (32.34M shares) as of its latest 13F filing.
What percentage of Pacific Biosciences of California is owned by institutions?
Institutions own about 55.4% of PACB shares and 60.9% of the public float.
How much of Pacific Biosciences of California do insiders own?
Insiders, such as officers and directors, own about 8.91% of PACB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.